Condition
Crohn's Disease (CD) clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Crohn's Disease (CD) clinical trials that are recruiting, at sites in 19 countries (most in United States (6), United Kingdom (2), Russia (1)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 19Countries
Newest Crohn's Disease (CD) clinical trials
All recruiting trials (8)
-
Ultrasound-guided margin choice during ileocolic resection for Crohn's disease
This trial tests whether using ultrasound to guide how much tissue to remove during ileocolic surgery for terminal ileal Crohn's disease helps people see better outcomes than using the usual surgeon-determined margins.
-
Tailored Anti-Inflammatory Diet for Crohn's Disease
This study tests a personalized anti-inflammatory diet for people with Crohn’s disease to see if it improves symptoms and inflammation and to find biomarkers of response.
-
Ketogenic versus Carnivore (Lion) diets for inflammatory bowel disease and rheumatoid arthritis
This trial will test whether a ketogenic diet or a carnivore (lion) diet can reduce symptoms, improve quality of life, and lower inflammation in adults with IBD or rheumatoid arthritis.
-
Biologics plus a 6-week enteral nutrition plan for children with Crohn's disease
This will test whether giving children and teens (6–18) with active Crohn's disease a 6-week specialised liquid diet alongside biologic drugs helps them achieve and stay in remission.
-
Over-the-counter pain medicine comparison for period cramps in women with Crohn's disease
This pilot will test whether ibuprofen or acetaminophen relieves period cramps more effectively and safely for women aged 18–44 who have Crohn's disease in remission.
-
Zymfentra (infliximab-dyyb) real-world cohort
This project will see if Zymfentra (infliximab-dyyb) reduces symptoms over one year in adults with Crohn's disease, ulcerative colitis, or indeterminate colitis who are starting or switching to the drug as part of routine care.
-
BCD-261 (anti‑TL1A) treatment for adults with moderate to severe Crohn's disease testing several dose regimens
This trial will test whether different doses of the anti‑TL1A antibody BCD-261 help adults with moderate to severe Crohn's disease who have not responded to steroids, immunosuppressants, or biologics.
-
Treatment of moderate to severe Crohn's disease in children and teenagers with vedolizumab
This study is testing if a new medication called vedolizumab can help children and teenagers with moderate to severe Crohn's disease feel better and reduce inflammation in their digestive system.
Related topics
Quick answers
How many Crohn's Disease (CD) clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 19 countries. The most sites are in United States (6 trials), United Kingdom (2 trials), Russia (1 trial), Australia (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.